External Opportunity - Chief Executive Officer, Organ And Tissue Authority

• Statutory Appointment - Fulltime, Specified term up to 5 years
• Canberra, ACT
• Contact: Karina Duffey at Executive Intelligence Group (Phone: 02 6232 2200; Email: admin@execintell.com.au)

The Organ and Tissue Authority (OTA), Chief Executive Officer (CEO) is a full-time statutory office holder established under Section 14 of the OTA Act. Under the OTA Act, the OTA CEO is to be appointed on a full-time basis by the Minister through written instrument.

The functions of the CEO are:

• To determine objectives, strategies and policies to be followed by the Authority in the performance of its functions;
• To ensure the proper, efficient and effective performance of the Authority's functions;
• To manage the administration of the Authority;
• Such other functions as are conferred on the CEO by this Act or any other law;
• To do anything incidental or conductive to the performance of any of the above functions.

The CEO must perform their duties and responsibilities in accordance with the OTA Act, in addition to the values and behaviour required of an Australian Public Service employee under the Public Service Act 1999 (Cth) and in accordance with the Public Governance, Performance and Accountability Act 2013.

It is intended that the next OTA CEO will commence from 1 October 2026 for a term of up to 5 years.